Logo image of ICG

INTCHAINS GROUP LTD-ADR (ICG) Stock Fundamental Analysis

NASDAQ:ICG - Nasdaq - US45828E1047 - ADR - Currency: USD

1.19  -0.54 (-31.21%)

After market: 1.38 +0.19 (+15.97%)

Fundamental Rating

5

Overall ICG gets a fundamental rating of 5 out of 10. We evaluated ICG against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. While ICG has a great health rating, its profitability is only average at the moment. ICG shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ICG had positive earnings in the past year.
ICG had a negative operating cash flow in the past year.
Of the past 5 years ICG 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: ICG reported negative operating cash flow in multiple years.
ICG Yearly Net Income VS EBIT VS OCF VS FCFICG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

1.2 Ratios

The Return On Assets of ICG (4.69%) is better than 62.73% of its industry peers.
The Return On Equity of ICG (5.05%) is comparable to the rest of the industry.
ICG has a Return On Invested Capital (1.93%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 4.69%
ROE 5.05%
ROIC 1.93%
ROA(3y)13.06%
ROA(5y)26.3%
ROE(3y)13.41%
ROE(5y)28.41%
ROIC(3y)N/A
ROIC(5y)N/A
ICG Yearly ROA, ROE, ROICICG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

ICG has a Profit Margin of 18.21%. This is in the better half of the industry: ICG outperforms 77.27% of its industry peers.
In the last couple of years the Profit Margin of ICG has declined.
ICG has a Operating Margin (8.81%) which is in line with its industry peers.
In the last couple of years the Operating Margin of ICG has declined.
The Gross Margin of ICG (53.38%) is better than 70.00% of its industry peers.
In the last couple of years the Gross Margin of ICG has grown nicely.
Industry RankSector Rank
OM 8.81%
PM (TTM) 18.21%
GM 53.38%
OM growth 3Y-50.5%
OM growth 5YN/A
PM growth 3Y-36.68%
PM growth 5YN/A
GM growth 3Y-13.04%
GM growth 5Y25.49%
ICG Yearly Profit, Operating, Gross MarginsICG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICG is destroying value.
ICG has about the same amout of shares outstanding than it did 1 year ago.
ICG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ICG Yearly Shares OutstandingICG Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M
ICG Yearly Total Debt VS Total AssetsICG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

ICG has an Altman-Z score of 6.16. This indicates that ICG is financially healthy and has little risk of bankruptcy at the moment.
ICG has a better Altman-Z score (6.16) than 66.36% of its industry peers.
There is no outstanding debt for ICG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.16
ROIC/WACC0.22
WACC8.6%
ICG Yearly LT Debt VS Equity VS FCFICG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

ICG has a Current Ratio of 9.49. This indicates that ICG is financially healthy and has no problem in meeting its short term obligations.
ICG has a Current ratio of 9.49. This is amongst the best in the industry. ICG outperforms 95.45% of its industry peers.
ICG has a Quick Ratio of 8.18. This indicates that ICG is financially healthy and has no problem in meeting its short term obligations.
ICG's Quick ratio of 8.18 is amongst the best of the industry. ICG outperforms 95.45% of its industry peers.
Industry RankSector Rank
Current Ratio 9.49
Quick Ratio 8.18
ICG Yearly Current Assets VS Current LiabilitesICG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 295.45% over the past year.
Measured over the past years, ICG shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -51.46% on average per year.
Looking at the last year, ICG shows a very strong growth in Revenue. The Revenue has grown by 242.96%.
ICG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.10% yearly.
EPS 1Y (TTM)295.45%
EPS 3Y-51.46%
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)242.96%
Revenue growth 3Y-23.58%
Revenue growth 5Y51.1%
Sales Q2Q%442.81%

3.2 Future

ICG is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.50% yearly.
ICG is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 249.03% yearly.
EPS Next Y59.27%
EPS Next 2Y0.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year403.52%
Revenue Next 2Y249.03%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ICG Yearly Revenue VS EstimatesICG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
ICG Yearly EPS VS EstimatesICG Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.05 0.1 0.15 0.2

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 59.50, the valuation of ICG can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ICG is on the same level as its industry peers.
When comparing the Price/Earnings ratio of ICG to the average of the S&P500 Index (26.35), we can say ICG is valued expensively.
A Price/Forward Earnings ratio of 65.05 indicates a quite expensive valuation of ICG.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ICG indicates a slightly more expensive valuation: ICG is more expensive than 63.64% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ICG to the average of the S&P500 Index (22.19), we can say ICG is valued expensively.
Industry RankSector Rank
PE 59.5
Fwd PE 65.05
ICG Price Earnings VS Forward Price EarningsICG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ICG indicates a somewhat cheap valuation: ICG is cheaper than 70.91% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.61
ICG Per share dataICG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

ICG's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1
PEG (5Y)N/A
EPS Next 2Y0.5%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ICG!.
Industry RankSector Rank
Dividend Yield N/A

INTCHAINS GROUP LTD-ADR

NASDAQ:ICG (6/20/2025, 8:00:02 PM)

After market: 1.38 +0.19 (+15.97%)

1.19

-0.54 (-31.21%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-22 2025-05-22/amc
Earnings (Next)N/A N/A
Inst Owners0.7%
Inst Owner Change366.61%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap71.84M
Analysts80
Price Target7.4 (521.85%)
Short Float %0.22%
Short Ratio0.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-40.59%
Min EPS beat(2)-60.4%
Max EPS beat(2)-20.79%
EPS beat(4)1
Avg EPS beat(4)-7.92%
Min EPS beat(4)-147.52%
Max EPS beat(4)197.03%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-38.44%
Min Revenue beat(2)-40.57%
Max Revenue beat(2)-36.31%
Revenue beat(4)1
Avg Revenue beat(4)-9.78%
Min Revenue beat(4)-40.57%
Max Revenue beat(4)38.77%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-23.68%
PT rev (3m)-34.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)54.55%
EPS NY rev (1m)-26.79%
EPS NY rev (3m)-58.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)348.92%
Revenue NY rev (1m)1.53%
Revenue NY rev (3m)187.82%
Valuation
Industry RankSector Rank
PE 59.5
Fwd PE 65.05
P/S 1.83
P/FCF N/A
P/OCF N/A
P/B 0.51
P/tB 0.51
EV/EBITDA 17.61
EPS(TTM)0.02
EY1.68%
EPS(NY)0.02
Fwd EY1.54%
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS0.65
BVpS2.34
TBVpS2.33
PEG (NY)1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.69%
ROE 5.05%
ROCE 2.44%
ROIC 1.93%
ROICexc 1.93%
ROICexgc 1.94%
OM 8.81%
PM (TTM) 18.21%
GM 53.38%
FCFM N/A
ROA(3y)13.06%
ROA(5y)26.3%
ROE(3y)13.41%
ROE(5y)28.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-83.94%
ROICexcg growth 5YN/A
ROICexc growth 3Y-83.96%
ROICexc growth 5YN/A
OM growth 3Y-50.5%
OM growth 5YN/A
PM growth 3Y-36.68%
PM growth 5YN/A
GM growth 3Y-13.04%
GM growth 5Y25.49%
F-Score5
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 221.73%
Cap/Sales 3.56%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.49
Quick Ratio 8.18
Altman-Z 6.16
F-Score5
WACC8.6%
ROIC/WACC0.22
Cap/Depr(3y)583.15%
Cap/Depr(5y)424.89%
Cap/Sales(3y)21.73%
Cap/Sales(5y)13.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)295.45%
EPS 3Y-51.46%
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y59.27%
EPS Next 2Y0.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)242.96%
Revenue growth 3Y-23.58%
Revenue growth 5Y51.1%
Sales Q2Q%442.81%
Revenue Next Year403.52%
Revenue Next 2Y249.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y138.13%
EBIT growth 3Y-62.17%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-170.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2829.94%
OCF growth 3YN/A
OCF growth 5YN/A